Pharmaceutical Supply, Pharmaceutical Manufacturing, Contract Research, Pharmaceutical Outsourcing

Top Headlines

Catalent investing $5m to bolster early development offering

Catalent plans to invest $5m to create a new drug development center of excellence focusing on preclinical to clinical phase IIb formulation, analytical, and manufacturing solutions.

In the search of a universal flu vaccine

Following one of the worst flu seasons in years, several companies are working to develop a universal vaccine, with the first clinical trials in humans now underway.

CPhI North America: Live updates from Philadelphia

We have arrived in Philadelphia to report on the major trends at CPhI North America including continuous manufacturing, cell and gene therapies, and the changing nature of contract service relationships.

Sizing up: Does CRO consolidation leave space for smaller firms?

A continued need for specialized services and expertise will keep smaller firms in business – though many have forecasted the “death of small- to mid-sized CROs” as the industry continues to consolidate, say experts.

Acurian, Synexus tap database of 100m for NASH patient enrollment solution

Acurian and Synexus have introduced a new clinical trial enrollment solution for patients with nonalcoholic fatty liver disease, which is often underdiagnosed.

STA to manufacture PhoenixMD candidate for Ph I study

STA Pharmaceutical is manufacturing PhoenixMD’s kinase inhibitor drug candidate for IND-enabling toxicology studies and a Phase I study in women with triple-negative breast cancer.

Glenmark suspends Ph II clinical trial at Indian site following alleged ‘irregularities’

Glenmark Pharmaceuticals has suspended a Phase II clinical trial at a site in India following media reports that villagers were allegedly “deceived” into participating.

WuXi AppTec opens second NJ-based site following ongoing expansion efforts

WuXi AppTec is converting its Plainsboro, NJ lab into a fully GLP-regulated bioanalytics facility after opening a new site in Cranbury which doubles the company’s total operation space to more than 115,000 square feet.

Promotional Features

Content provided by R-Pharm Germany GmbH

New Track & Trace User Academy: Reducing the ramp up time by observing and learning T&T in the wild

Major markets are mandating the implementation of serialization. The new Track & Trace User Academy brings personnel up to speed on using equipment and processes correctly.